Dey Svetlana

SEC Form 4 insider trading activity

Dey Svetlana has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.

On the most recent filing, Dey Svetlana is listed as Director at Bluejay Diagnostics, Inc. Inside the rolling window, Dey Svetlana reported 1 open-market purchase totaling $25K in BJDX and no open-market sales.

Companies traded

Other insiders at BJDX

Insider Buying

$25K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BJDX
Dey Svetlana
Purchase$25KMay 18SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Dey Svetlana made?

Dey Svetlana has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Dey Svetlana trade?

Dey Svetlana has filed SEC Form 4 disclosures for 1 company, including BJDX.

When was Dey Svetlana's most recent SEC Form 4 filing?

Dey Svetlana's most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.

What is Dey Svetlana's total buy and sell value in the current window?

Inside the rolling retention window, Dey Svetlana bought $25K and sold $0 based on SEC Form 4 filings.

What was Dey Svetlana's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 12,500 BJDX shares on 2026-03-14, worth $25K, per SEC Form 4 filings.